540694 — ANG Lifesciences India Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for ANG Lifesciences India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	38.6	183	185	173	133
Net Total Accounts Receivable
Net Total Receivables	820	1,021	1,123	733	665
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,159	1,928	1,869	1,789	1,653
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	239	926	881	584	572
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,437	2,910	2,797	2,424	2,296
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	916	1,663	1,623	1,446	1,434
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1,021	2,073	1,935	1,662	1,656
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	416	838	862	763	640
Total Liabilities & Shareholders' Equity	1,437	2,910	2,797	2,424	2,296
Total Common Shares Outstanding